KDM1A and neoplasm: LSD1 exerts direct and indirect regulatory effects on immune checkpoints, notably CD47 and PD-L1, which mediate tumor immune escape via the SIRPα/CD47 and PD-1/PD-L1 pathways, respectively [184].